publicações selecionadas
-
artigo académico
- Enhancement of Acetate-Induced Apoptosis of Colorectal Cancer Cells by Cathepsin D Inhibition Depends on Oligomycin A-Sensitive Respiration. Biomolecules. 2024
- Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy. International Journal of Molecular Sciences. 2023
- Novel Benzo[a]phenoxazinium Chlorides Functionalized with Sulfonamide Groups as NIR Fluorescent Probes for Vacuole, Endoplasmic Reticulum, and Plasma Membrane Staining. International Journal of Molecular Sciences. 2023
- Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy. Medical Oncology. 2022
- Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs. Pharmaceutics. 2022
- Monocarboxylate Transporters as Targets and Mediators in Cancer Therapy Response. Histology and Histopathology. 2014
- BRAFV600E mutation in papillary thyroid carcinoma: A potential target for therapy?. Expert Review of Endocrinology and Metabolism. 2009
- BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600Ebut not KRAS mutations. Journal of Pathology. 2008
- Intragenic Mutations in Thyroid Cancer. Endocrinology and Metabolism Clinics of North America. 2008
- A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation. Virchows Archiv. 2007
- KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene. 2007
- Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid. 2007
- Molecular genetics of papillary thyroid carcinoma - Great expectations.... Arquivos Brasileiros de Endocrinologia e Metabologia. 2007
- A stem cell role for thyroid solid cell nests [1] (multiple letters). Human Pathology. 2005
- Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene. 2005
- Molecular pathology of well-differentiated thyroid carcinomas. Virchows Archiv. 2005
- Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid. British Journal of Cancer. 2005
- Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Archiv. 2005
- Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC Cancer. 2004
- Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Modern Pathology. 2004
- Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: Implications for antitelomerase therapy. Oncogene. 2004
- BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003
- P63 expression in papillary and anaplastic carcinomas of the thyroid gland: Lack of an oncogenetic role in tumorigenesis and progression. Pathology Research and Practice. 2002
- Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a. Gene. 1999
-
artigo de conferência
- Monocarboxylate transporters expression is influenced by different extracellular conditions determining the effect of 3-bromopyruvate in colorectal cancer cells 2018
- Improved production of acetate and propionate by Propionibacterium freudenreichii 2014
- Liposomal formulations for specific drug delivery 2013
- Enhancing 5-FU activity in colorectal carcinoma-derived cell lines: combination with monocarboxylate transporter inhibitors and encapsulation into zeolites 2012
- Monocarboxylate transporters - new molecular targets for colorectal carcinoma? 2011
- Monocarboxylate transporters as new attractive targets for colorectal carcinoma therapy 2011
- Monocarboxylate transporters: new molecular targets for colorectal carcinoma 2011
- New synthetic raloxifen-like di(hetero)arylamines induce apoptosis and inhibit the estrogen receptor in breast cancer cells 2011
- Vacuole-mitochondrial crosstalk during apoptosis induced by acetic acid in yeast 2011
- What yeast can tell us about how cells commit suicide? 2011
-
artigo de revista
- New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential. Pharmaceutics. 2023
- Novel benzo[α]phenoxazinium chlorides functionalized with sulfonamide groups as NIR fluorescent probes for vacuole, endoplasmic reticulum, and plasma membrane staining. International Journal of Molecular Sciences. 2023
- Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative. International Journal of Molecular Sciences. 2022
- Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy. Pharmaceutics. 2022
- Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy. Medical Oncology. 2022
- Crucial Role of Oncogenic KRAS Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications. Cells. 2022
- Ruthenium(II)–cyclopentadienyl-derived complexes as new emerging anti-colorectal cancer drugs 2022
- Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics. 2022
- KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications. Cells. 2022
- Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer. Food Bioscience. 2022
- Novel Nile Blue Analogue Stains Yeast Vacuolar Membrane, Endoplasmic Reticulum, and Lipid Droplets, Inducing Cell Death through Vacuole Membrane Permeabilization. Journal of Fungi. 2021
- The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications. Current Medicinal Chemistry. 2020
- A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity Against Colorectal and Triple Negative Breast Cancer Cells.. Molecules (Basel, Switzerland). 2020
- Ruthenium–Cyclopentadienyl Bipyridine–Biotin Based Compounds: Synthesis and Biological Effect. Inorganic Chemistry. 2019
- Polymer “ruthenium-cyclopentadienyl” conjugates - New emerging anti-cancer drugs. European Journal of Medicinal Chemistry. 2019
- Extracellular conditions influence the MCT1, MCT4 and CD147 expression and 3-bromopyruvate effect in colorectal cancer cells. Biological Chemistry. 2019
- The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis. Cells. 2018
- Colorectal cancer cells increase the production of short chain fatty acids by Propionibacterium freudenreichii impacting on cancer cells survival. Frontiers in Nutrition. 2018
- Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells. Current Medicinal Chemistry. 2018
- Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells. European Journal of Medicinal Chemistry. 2018
- Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. Colloids and Surfaces B: Biointerfaces. 2017
- Folate-targeted nanoparticles for rheumatoid arthritis therapy. Analytical Chemistry. 2016
- Assessment of liposome disruption to quantify drug delivery in vitro. Biochimica et Biophysica Acta (BBA). Biomembranes. 2016
- Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications. Oncotarget. 2016
- Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer. 2016
- The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. Journal of Bioenergetics and Biomembranes. 2016
- Design of liposomal formulations for cell targeting. Colloids and Surfaces B: Biointerfaces. 2015
- Enhancing Methotrexate Tolerance with Folate Tagged Liposomes in Arthritic Mice. Journal of Biomedical Nanotechnology. 2015
- Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells. Cancer Letters. 2015
- Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors. Analytical Chemistry. 2015
- Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria. Cell Death and Differentiation. 2015
- Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy. Oncotarget. 2015
- Peptide Anchor for Folate-Targeted Liposomal Delivery. Biomacromolecules. 2015
- RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation. Molecular and Cellular Endocrinology. 2015
- Size controlled protein nanoemulsions for active targeting of folate receptor positive cells. Colloids and Surfaces B: Biointerfaces. 2015
- The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH. Biochemical Journal. 2015
- Yeast as a tool to explore cathepsin D function. Microbial Cell. 2015
- Monocarboxylate transporters as targets and mediators in cancer therapy response. Histology and Histopathology. 2014
- Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release. Cell Death and Differentiation. 2013
- Frequency of TERT promoter mutations in human cancers. Nature Communications. 2013
- In vitro induction of melanin synthesis and extrusion by tamoxifen. International Journal of Cosmetic Science. 2013
- Liposome and protein based stealth nanoparticles. Faraday Discussions. 2013
- 3-bromopyruvate, butyrate, monocarboxylate transporters, warburg effect. Journal of Bioenergetics and Biomembranes. 2012
- Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current Genomics. 2011
- Vacuole-mitochondrial cross-talk during apoptosis in yeast: A model for understanding lysosome-mitochondria-mediated apoptosis in mammals. Biochemical SocIETy Transactions. 2011
- Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Letters. 2009
- Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer. 2009
- Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Archiv. 2003
- p63 expression in solid cell nests of the thyroid: Further evidence for a stem cell origin. Modern Pathology. 2003
-
capítulo de livro
-
documento
- New Iron(II)-Cyclopentadienyl Compounds Show High Therapeutic Potential against Colorectal Cancer Cells 2024
- Estudo da atividade cancerígena de compostos de ferro (FeCp) em linhas de cancro colorretal 2023
- New ruthenium-cyclopentadienyl agents as a new strategy to fight colorectal cancer 2021
- The potential of novel benzo[a]phenoxazine derivatives for colorectal cancer treatment 2021
- Dissecting the impact of KRAS/Galectin-3 complex in colorectal cancer. 2021
- Oncogenic KRAS mutations may modulate the pro-apoptotic protein BAX activity 2021
- Ruthenium-based anticancer agents: new therapeutic approach against colorectal cancer. 2021
- The anticancer effect of a novel Benzo[a]phenoxazine derivative targeting lysosomes in colorectal cancer cells 2021
- Effect of diet microbiota-derived short-chain fatty acids in colorectal cancer cells 2021
- Targeting glycolytic metabolism as a therapeutic strategy for Acute Myeloid Leukemia 2021
- Colorectal cancer cells-macrophages interplay: the role of KRAS and Galectin-3 2021
- Ruthenium-based agents as promising metallodrugs to fight colorectal cancer 2020
- Unravel the role of KRAS/galectin-3 loop in colorectal microenvironment 2020
- Fighting colorectal cancer with ruthenium-based agents 2020
- New ruthenium-based agents target actin cytoskeleton in colorectal cancer cells 2020
- The impact of KRAS/galectin-3 loop in colorectal tumor microenvironment 2020
- The role of microbiota-derived short chain fatty acids in the modulation of colorectal cancer glycolytic metabolism and extracellular pH 2020
- Unveil the role of KRAS mutations in glycolytic metabolism 2020
- 3-bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by reducing cell antioxidant defense 2020
- Non-toxic concentrations of 3-bromopyruvate sensitize acute leukemia cells to chemotherapy by inducing oxidative stress 2020
- Mestrado em Biofísica e Bionanossistemas: comemoração da 10ª edição 2019
- New ruthenium-biotinylated anticancer agents for colorectal cancer therapy 2019
- New ruthenium-biotinylated anticancer agent for colorectal cancer therapy 2019
- Unveiling the role of diet microbiome-derived short chain fatty acids in colorectal cancer metabolism. 2019
- Discovering the molecular targets of new ruthenium-based anticancer agents for colorectal cancer therapy 2019
- 3-Bromopyruvate pre-treatment sensitizes MOLM13 and KG-1 cell lines to chemotherapy. 2019
- Uncovering the role of acetate in the prevention of colorectal cancer induced by food contaminants. 2019
- 3-Bromopyruvate pre-treatment sensitizes MOLM13 and KG-1 cell lines to chemotherapy 2019
- Acetate as a possible protective agent against food contaminants in human colon 2019
- Benzo[a]phenoxazines derivatives as potential novel agents for colorectal cancer therapy 2019
- Dissecting the impact of KRAS/Galectin-3 complex at the colorectal tumor microenvironment 2019
- New ruthenium-based anticancer agents: uncovering the molecular targets towards colorectal cancer therapy 2019
- Oncogenic KRAS mutations may modulate the activity of pro-apoptotic protein BAX at the mitochondria 2019
- Reciprocal interaction between pro-apoptotic BAX and oncogenic KRAS mutants 2019
- The anticancer potential of novel Benzo[a]phenoxazines derivatives for colorectal cancer treatment 2019
- Uncovering the role of acetate in the prevention of colorectal cancer induced by food contaminants 2019
- Unravel the role of KRAS/Galectin-3 loop in the crosstalk between colorectal cancer cells and tumor-associated macrophages 2019
- Unveiling the role of microbiome-derived short chain fatty acids in colorectal cancer metabolism 2019
- Unveilling the role of actin regulation on KRAS-induced autophagy using C. elegans as an in vivo model 2019
- The role of acetate in oncogene signalling activation and metabolism in colorectal cancer. 2018
- Uncovering the role of acetate in the crosstalk between monocarboxylate transporters and oncogene signaling pathways in colorectal cancer 2018
- Identification of a novel KRAS/Galectin-3/p16INK4a triple axis in colorectal cancer: therapeutic implications 2018
- Monocarboxylate transporters expression is influenced by different extracellular conditions determining the effect of 3-bromopyruvate in colorectal cancer cells 2018
- New ruthenium-based anticancer agents: a promising therapeutic approach to colorectal cancer 2018
- The role of acetate in oncogene signalling activation and metabolism in colorectal cancer 2018
- Uncovering the role of acetate in the crosstalk between monocarboxylate transporters and oncogene signalling pathways in colorectal cancer 2018
- Unraveling the molecular targets of new ruthenium compounds towards colorectal cancer therapy 2018
- Unveil the role of actin on KRAS induced autophagy in colorectal cancer, using Caenorhabditis elegans as an in vivo model 2018
- Mitochondrial ROS accumulation sensitizes colorectal cancer cells to acetate and Cathepsin D inhibitors combination therapy 2017
- Cancer targeted therapy: the next generation of metallodrugs 2017
- Characterization of the signaling pathways associated with the effect of acetate in colorectal cancer cells 2017
- Understanding the role of KRAS hotspot mutations in the regulation of the p16INK4a/KRAS/Galectin-3 axis in colorectal cancer 2017
- Unraveling the mode of action of new promising polymer-ruthenium conjugates 2017
- Targeting glycolysis in acute myeloid leukemia: therapeutic applications. 2016
- Transport of short chain fatty acids and 3-bromopyruvate in cancer cells: implications for cancer therapy 2016
- Cathepsin D-mediated degradation of damaged mitochondria rescues colorectal cancer cells from acetate-induced apoptosis 2016
- Exploring multifunctional polymer-ruthenium conjugates as new promising anticancer agentes 2016
- Exploring the effect of multifunctional polymer-ruthenium conjugates: new promising anticancer agentes 2016
- Targeting glycolysis in acute myeloid leukemia: therapeutic applications 2016
- The extracellular pH influences the cytotoxicity and transport of 3-Bromopyruvate by monocarboxylate transporters in breast cancer cells 2016
- The extracellular pH influences the cytotoxicity and transport of 3-Bromopyruvate in breast cancer cells 2016
- Uncover The Role Of KRAS/Galectin-3/P16ink4a Axis Regulation In Colorectal Cancer 2016
- Understanding the role of oncogenic KRAS mutations in the regulation of mitochondria and Bax-mediated cell death 2016
- Unraveling the mode of action of new promising polymer-ruthenium conjugates 2016
- Lactate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells. 2015
- Cathepsin D is involved in the degradation of damaged mitochondria during acetate-induced apoptosis in colorectal cancer cells. 2015
- Cathepsin D is involved in the degradation of damaged mitochondria during acetate-induced apoptosis in colorectal cancer cells 2015
- Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria 2015
- Colon cancer-related mutant KRAS alleles function as positive regulators of autophagy 2015
- Folate-target liposomal nanoparticles for cancer therapy 2015
- Hotspot mutations in the KRAS oncogene function as positive regulators of autophagy in the colon 2015
- Monoolein-based nanocarriers for siRNA delivery in colorectal cancer therapy 2015
- Propionibacterium freudenreichii short-chain fatty acids inhibit the proliferation of colorectal cancer cells 2015
- Short chain fatty acids produced by Propionibacterium freudenreichii inhibit colorectal cancer cells survival 2015
- Silencing of Monocarboxylate transporters as a tool to study the role of 3-bromopyruvate in breast cancer 2015
- The cytotoxicity of 3-Bromopyruvate in breast cancer cells depends on extracellular pH 2015
- Unravel the mechanisms of acetate induced apoptosis in colorectal cancer 2015
- Acetate induces lysosomal membrane permeabilization, cathepsin D release and impairs autophagy in colorectal carcinoma cells 2014
- Cathepsin D protects colorectal carcinoma cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria: a new function unveiled by the yeast vacuolar protease Pep4p 2014
- Characterization of 3-bromopyruvate uptake in breast cancer cells 2014
- Improved production of acetate and propionate by Propionibacterium freudenreichii 2014
- Formulations for micelle formation comprising a protein and methods preparation thereof 2013
- Liposomes and corresponding production method 2013
- Exploiting monocarboxylate transporters as newmolecular targets for colorectal carcinomatherapy 2013
- Characterization of a new peptide as membrane anchor for the incorporation of ligand targeting into liposomes 2013
- Exploiting monocarboxylate transporters as newmolecular targets for colorectal carcinomatherapy. ets for colorectal carcinoma therapy 2013
- Involvement of lysosomal membrane permeabilization and cathepsin D release in colorectal carcinoma cells acetate-induced apoptosis 2013
- Study of the role of RAF-1 in MAPK signaling in thyroid cancer cells 2013
- 3-bromopyruvate cytotoxic effect in breast cancer cells is dependent of monocarboxylate transporters (MCT) expression and is enhanced by butyrate 2012
- Butyric acid increases monocarboxylate transporters (MCT) expression and enhances the cytotoxicity of the anti-tumoral agent 3-bromopyruvate (3-BP) in breast cancer cells 2012
- Combination of 5-FU with monocarboxylate transporters inhibitors as a new therapeutic approach in colorectal carcinoma 2012
- Enhancing 5-FU Activity in Colorectal Carcinoma-derived Cell Lines – Combination With Monocarboxylate Transporter Inhibitors and Encapsulation into Zeolites 2012
- Enhancing 5-FU activity in colorectal carcinoma-derived cell lines: combination with monocarboxylate transporter inhibitors and encapsulation into zeolites. European Journal of Cancer. 2012
- Liposomal formulations for specific drug delivery. Abstracts of Papers of the American Chemical SocIETy. 2012
- Tamoxifen speeds up melanin extrusion in normal human melanocytes 2012
- The role of KRAS mutations in autophagy regulation in colorectal carcinoma 2012
- The role of lysosomal membrane permeabilization in acetate-induced apoptosis in colorectal carcinoma cells 2012
- Transport of lactic acid across plasma membrane: implications in health and biotechnology 2012
- Unravel the role of KRAS in autophagy control in colorectal carcinoma: Saccharomyces cerevisiae as a model system 2012
- Using zeolites as systems for drug delivery in in vitro models of colorectal carcinoma 2012
- Vacuole-mitochondrial crosstalk during apoptosis induced by acetic acid in yeast 2011
- Monocarboxylate transporters - new molecular targets for colorectal carcinoma? 2011
- Monocarboxylate transporters as new attractive targets for colorectal carcinoma therapy 2011
- Monocarboxylate transporters – new molecular targets for colorectal carcinoma? 2011
- Monocarboxylate transporters: new molecular targets for colorectal carcinoma 2011
- New synthetic di(hetero)arylamines raloxifen-like induce apoptosis of breast cancer cells and specifically bind to estrogen receptor 2011
- New synthetic raloxifen-like di(hetero)arylamines induce apoptosis and inhibit the estrogen receptor in breast cancer cells 2011
- Vacuole-mitochondrial cross-talk during apoptosis in yeast: a model for understanding lysosome-mitochondria-mediated apoptosis in mammals 2011
- What yeast can tell us about how cells commit suicide? 2011
- Characterization of several liposomal formulations for methotrexate delivery 2010
- Effect of two di(hetero)arylamines raloxifen-like in proliferation and apoptosis of breast cancer cells 2010
- Response to acetate in colorectal carcinoma cells harboring different genetic backgrounds 2010
- The involvement of the lysosome in death induced by acetate in colorectal carcinoma cells harboring different genetic backgrounds 2010
- The role of human oncogene KRAS in autophagy regulation: Saccharomyces cerevisiae as a model system 2010
- Capillary treatments using siRNA oligonucleotides- a new gene therapy tool? 2009
- Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations 2009
- Effects of natural compounds in PI3K/AKT and MAPK/ERK pathway on human colorectal cell lines 2008
- Quercetin, Luteolin and ursolic acid are potent inhibitors of proliferation in colorectal carcinoma cells: new therapeutic tools? 2008
- Sinalização, expressão génica e regulação pós-transcricional: guião das aulas práticas 2008
- BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations 2007
- Novas terapêuticas no carcinoma da tireóide: efeito biológico da inibição farmacológica de cinases em linhas celulares do carcinoma da tiróide 2007
- Novas terapêuticas no carcinoma da tireóide: novos alvos moleculares? 2007
- RAF-1 in contrast to BRAF is not a mutational target of thyroid carcinogenesis 2004
- RASSF1A methylation analysis in a series of colorectal cancer cell lines: ongoing work 2004
- Distribution of p63, Cytokeratin 5/6 and Cytokeratin 14 in 51 Normal and 450 Neoplastic Human Tissue Samples Using TARP-4 Multi-Tumor Tissue Microarray 2003
- P53 mediated growth arrest in response to telomere erosion is retained in a subset of human cancer cell lines 2003
- P53 mediated growth arrest in response to telomere erosion is retained in a subset of human cancer cell lines 2002
- Telomerase inhibition in cancer cells retaining wild-type p53 2002
- p63 expression in papillary and anaplastic carcinomas of the thyroid gland 2002
- p63 in solid cell nests: further evidence for a stem cell origin 2002
- Efeito da inibição da telomerase em linhas celulares de carcinoma papilar da tireóide 2001
-
poster de conferência
- 3-bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by reducing cell antioxidant defense 2020
- Non-toxic concentrations of 3-bromopyruvate sensitize acute leukemia cells to chemotherapy by inducing oxidative stress 2020
- 3-Bromopyruvate pre-treatment sensitizes MOLM13 and KG-1 cell lines to chemotherapy 2019
-
teses